Tim Demuth
Chief Tech/Sci/R&D Officer presso MORPHOSYS AG
Profilo
Tim Demuth is Chief Research & Development Officer at MorphoSys AG.
In the past he occupied the position of Chief Medical Officer & Senior Vice President at Pieris Pharmaceuticals, Inc., VP & Head-Global Clinical Development Oncology at Merck KGaA and Head-Clinical Development at Sandoz AG.
Dr. Demuth received a doctorate from The Johannes Gutenberg University of Mainz.
Posizioni attive di Tim Demuth
Società | Posizione | Inizio |
---|---|---|
MORPHOSYS AG | Chief Tech/Sci/R&D Officer | 01/10/2022 |
Precedenti posizioni note di Tim Demuth
Società | Posizione | Fine |
---|---|---|
PIERIS PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 30/09/2022 |
Sandoz AG
Sandoz AG Pharmaceuticals: GenericHealth Technology Part of Novartis AG, Sandoz AG is a Swiss company that develops generic medicines and biosimilars. The private company is based in Basel, Switzerland. | Chief Tech/Sci/R&D Officer | - |
MERCK KGAA | Corporate Officer/Principal | - |
Formazione di Tim Demuth
The Johannes Gutenberg University of Mainz | Doctorate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 3 |
---|---|
MERCK KGAA | Health Technology |
MORPHOSYS AG | Health Technology |
PIERIS PHARMACEUTICALS, INC. | Health Technology |
Aziende private | 1 |
---|---|
Sandoz AG
Sandoz AG Pharmaceuticals: GenericHealth Technology Part of Novartis AG, Sandoz AG is a Swiss company that develops generic medicines and biosimilars. The private company is based in Basel, Switzerland. | Health Technology |